See the new paper in AAC evaluating ID-ODS in critically ill patients…

The paper titled Pharmacodynamic target attainment for cefepime, meropenem and piperacillin/tazobactam using a pharmacokinetic/pharmacodynamic-based dosing calculator in critically ill patients, published online ahead of print in AAC focused on evaluating ID-ODS simulations in critically ill patients. Over 20 percent of the time the simulator based optimal regimen was different from general dosing guidelines often used in clinical practice.